Cerebral venous thrombosis associated to subacute De Quervain's thyroiditis in a carrier for the G20210A mutation of the prothrombin gene;Trombosis venosa cerebral asociada a tiroiditis subaguda de De Quervain en una paciente con la mutación G20210A del gen de la protrombina

Revista de Neurologia

Volumn 39, Issue 6, 2004, Pages 533-535

  Madronero Vuelta A B ^a   Sanahuja Montesinos, J ^a   Bergua Llop, M ^b   Araguas Arasanz C ^a  

^a HOSPITAL UNIVERSITARI ARNAU DE VILANOVA   (Spain)

^b INSTITUT CATALÀ DE LA SALUT   (Spain)

Author keywords

Cerebral venous thrombosis; Coagulation; Hereditary disease; Prothrombin gene; Thrombophilia; Thyrotoxicosis

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; CORTICOSTEROID; PROTHROMBIN; RADIOACTIVE IODINE;

ADULT; ANTICOAGULANT THERAPY; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; FEMALE; GENE MUTATION; GENETIC ANALYSIS; HETEROZYGOTE DETECTION; HUMAN; MAGNETIC RESONANCE ANGIOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCLUSIVE CEREBROVASCULAR DISEASE; RISK FACTOR; SUBACUTE THYROIDITIS; SUPERIOR SAGITTAL SINUS;

EID: 8144223144     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.3906.2004272     Document Type: Article

References (18)

1. Bousser MG, Russell RR. Cerebral venous thrombosis. Londres: WB Saunders; 1997.
2. Schutta HS, Williams EC, Baranski BG, Sutula TP. Cerebral venous thrombosis with plasminogen deficiency. Stroke 1991; 22: 401-5.
3. Siegert CE, Smelt AH, De Bruin TW. Superior sagital sinus thrombosis and thyrotoxicosis: possible association in two cases. Stroke 1995; 26: 496-7.
4. Silburn PA, Sandstrom PA, Staples C, Mowat P, Boyle RS. Deep cerebral venous thrombosis presenting as an encephalitic illness. Postgrad Med J 1996; 72: 355-68.
5. Dulli DA, Luzzio CC, Williams EC, Schutta HS. Cerebral venous thrombosis and activated protein C resistance. Stroke 1996; 27: 1731-3.
6. Cheng SR, Chun CL, Cheng LL, Han JC, Yeh LK, Wu FC. Superior sagital sinus thrombosis induced by thyrotoxicosis. J Neurosurg 2001; 94: 130-2.
7. Verberne HJ, Fliers E, Prummel MF, Stam J, Brandjes DP, Wiersinga WM. Thyrotoxicosis as a predisposing factor for cerebral venous thrombosis. Thyroid 2000; 10: 607-10.
8. Maes J, Michotte A, Velkeniers B, Stadnik T, Jochmans K. Hyperthyroidism with increased factor VIII procoagulant protein as a predisposing factor for cerebral venous thrombosis. J Neurol Neurosurg Psychiatry 2002; 73: 458.
9. O'Hare AJ, Molloy E, Cahill M. Cerebral venous sinus thrombosis precipitaded by Graves' disease and factor V Leiden mutation. Ir Med J 2003; 96: 46-7.
10. Simone JV, Abildgaard CF, Schulman I. Blood coagulation in thyroid dysfunction. N Engl J Med 1965; 273: 1057-61.
11. Koster T, Blann AD, Briet E, Vandenbroucke JP, Rosendaal FR. Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis. Lancet 1995; 345: 152-5.
12. Barrera P, Van Daal WA, Strijk SP, De Pauw BE. Subacute or De Quervain's thyroiditis and deep venous thrombosis 8 years after radio- and chemotherapy for Hodgkin's disease. Neth J Med 1990; 36: 200-3.
13. Poort SR, Rosendaal E, Reitsma P, Bertina R. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated prothrombin levels and an increase in venous thrombosis. Blood 1996; 88: 3698-703.
14. Ridker PM, Hennekens CH, Miletich JP. G20210A mutation in prothrombin gene and risk of myocardial infarction, stroke, and venous thrombosis in a large cohort of US men. Circulation 1999; 99: 999-1004.
15. Souto JC, Coll I, Llobet D, Del Rio E, Oliver A, Mateo J, et al. The prothrombin 20210A allele is the most prevalent genetic risk factor for venous thromboembolism in the Spanish population. Thromb Haemost 1998; 80: 366-9.
16. Martinelli I, Sacchi E, Landi G, Taioli E, Duca F, Mannucci PM. High risk of cerebral-vein thrombosis in carriers of a prothrombin-gene mutation and in users of oral contraceptives. N Engl J Med 1998; 338: 1793-7.
17. Reuner K, Ruf A, Grau A, Rickmann H, Stolz E, Juttler E, et al. Prothrombin gene G20210→A transition is a risk factor for cerebral venous thrombosis. Stroke 1998; 29: 1765-9.
18. Biousse V, Conard J, Brouzes C, Horellou MH, Ameri A, Bousser MG. Frequency of the 20210 G→A mutation the 3′-untranslated region of the prothrombin gene in 35 cases of cerebral venous thrombosis. Stroke 1998; 29: 1398-400.